Uncategorized
AstraZeneca wins EU backing for breast cancer drug, splitting with FDA panel
AstraZeneca wins EU backing for breast cancer drug, splitting with FDA panel
An AstraZeneca breast cancer drug received a positive opinion from European regulators, despite an FDA advisory committee voting against the drug last month. Novo Nordisk’s Wegovy pill also got the EU go-ahead.
The European Medicines … Read More